COR
Cencora, Inc.
Medical Distribution · Healthcare · United States
330.53
close · 2026-10-29
value
57
cheaper than peers57
quality
48
stronger fundamentals48
ranked against
Healthcare
value
quality
547 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.19× | 99 |
| forward P/E | 16.72× | 59 |
| EV to EBITDA | 13.71× | 57 |
| price to book | 20.67× | 8 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 107.1% | 98 |
| operating margin | 1.7% | 67 |
| revenue growth | 3.8% | 34 |
| debt to equity | 421.0% | 6 |
4 of 4 measures available
Facts
| market cap | $63B |
| free cash flow | -$318.2M |
| employees | 47,000 |
| first trade | 1995-04-04 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 7.96 | 7.53 | 8.53 | 8.04 |
| free cash flow | $3.21B | $3.00B | $3.45B | $2.21B |
| net income | $1.55B | $1.51B | $1.75B | $1.70B |
| revenue | $321.33B | $293.96B | $262.17B | $238.59B |
| unusual items | -$1.31B | -$981.7M | -$344.9M | -$387.1M |